Forbes contributors publish independent expert analyses and insights. We provide aggregated data on dividend stocks. Sep 04, 2025, 10:21am EDT On 9/8/25, Alphabet, Becton, Dickinson, and Rogers ...

Shareholders of Becton, Dickinson & Co (Symbol: BDX) looking to boost their income beyond the stock's 2.5% annualized dividend yield can sell the December covered call at the $175 strike and collect ...

We came across a bullish thesis on Becton, Dickinson and Company on Value Don't Lie’s Substack. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2026 Earnings Call Transcript February 9, 2026 Becton, Dickinson and Company beats earnings expectations. Reported EPS is $2.91, expectations were $2.81.

First Eagle Investments, an investment management company, released its “First Eagle Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Class A shares of ...

In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $200.43/share. When a stock reaches the ...

Buying value stocks probably won’t make for great conversation starters at cocktail parties, nor should it be. That’s because good investing isn’t a popularity contest that’s just about buying good ...

Becton, Dickinson (NYSE:BDX) is gearing up to announce its quarterly earnings on Monday, 2026-02-09. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Becton, Dickinson and Company delivered a Q1 2026 earnings beat, with $2.91 Non-GAAP EPS and $5.25B revenue, surpassing expectations. BDX completed the spin-off of its Life Sciences & Diagnostic ...

Becton Dickinson’s BDX-1.53%decrease; red down pointing triangle plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and diagnostic solutions business ...

Becton Dickinson's board has bumped up the quarterly dividend by a penny, or about 1%, to $1.05, extending the medical-technology company's royal payout status. The new quarterly rate, equal to $4.20 ...